Skip to Content

OncBioMune Pharmaceuticals Inc

Rating as of

Company Profile

Business Description

OncBioMune Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in the development of novel cancer immunotherapy products, with a proprietary vaccine technology that is designed to stimulate the immune system to attack its own cancer while not hurting the patient. The company is also developing and commercializing specialty drugs in Mexico and other Latin American countries. Its lead product candidate is ProscaVax, which is a prostate cancer vaccine. It has also developed a mouse model to test a whole-cell mouse mammary cancer vaccine.

11441 Industriplex Boulevard, Suite 190
Baton Rouge, LA, 70809
T +1 225 227-2384
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Mar 31, 2020
Fiscal Year End Dec 31, 2020
Stock Type Slow Growth
Employees 2